Pfizer Inc. and BioNTech SE announced on Wednesday a partnership with The Biovac Institute in Cape Town to manufacture the companies' mRNA coronavirus vaccine in South Africa, APA reports citing Teletrader.
According to the companies, Biovac will take over the manufacturing of over 100 million doses of the Pfizer/BioNTech shot per year to be distributed within the 55 member states of the African Union.
"Our latest collaboration with Biovac is a shining example of the tireless work being done, in this instance to benefit Africa. We will continue to explore and pursue opportunities to bring new partners into our supply chain network, including in Latin America, to further accelerate access of COVID-19 vaccines," Pfizer CEO Albert Bourla said of the deal.
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
